HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Doxycycline effects on serum bone biomarkers in post-menopausal women.

Abstract
We previously demonstrated that subantimicrobial-dose-doxycycline (SDD) treatment of post-menopausal osteopenic women significantly reduced periodontal disease progression, and biomarkers of collagen destruction and bone resorption locally in periodontal pockets, in a double-blind placebo-controlled clinical trial. We now hypothesize that SDD may also improve biomarkers of bone loss systemically in the same women, consistent with previous studies on tetracyclines (e.g., doxycycline) in organ culture and animal models of bone-deficiency disease. 128 post-menopausal osteopenic women with chronic periodontitis randomly received SDD or placebo tablets daily for 2 years adjunctive to periodontal maintenance therapy every 3-4 months. Blood was collected at baseline and at one- and two-year appointments, and sera were analyzed for bone resorption and bone formation/turnover biomarkers. In subsets of the study population, adjunctive SDD significantly reduced serum biomarkers of bone resorption (biomarkers of bone formation were unaffected), consistent with reduced risk of future systemic bone loss in these post-menopausal women not yet on anti-osteoporotic drugs.
AuthorsL M Golub, H-M Lee, J A Stoner, R A Reinhardt, T Sorsa, A D Goren, J B Payne
JournalJournal of dental research (J Dent Res) Vol. 89 Issue 6 Pg. 644-9 (Jun 2010) ISSN: 1544-0591 [Electronic] United States
PMID20348487 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Biomarkers
  • Collagen Type I
  • Peptide Fragments
  • Peptides
  • Placebos
  • Procollagen
  • collagen type I trimeric cross-linked peptide
  • Osteocalcin
  • Alkaline Phosphatase
  • Doxycycline
Topics
  • Absorptiometry, Photon
  • Alkaline Phosphatase (blood)
  • Anti-Bacterial Agents (blood, therapeutic use)
  • Biomarkers (blood)
  • Bone Diseases, Metabolic (blood)
  • Bone Remodeling (physiology)
  • Bone Resorption (blood)
  • Chromatography, High Pressure Liquid
  • Chronic Periodontitis (drug therapy, therapy)
  • Collagen Type I (blood)
  • Double-Blind Method
  • Doxycycline (blood, therapeutic use)
  • Female
  • Follow-Up Studies
  • Humans
  • Osteocalcin (blood)
  • Osteogenesis (physiology)
  • Peptide Fragments (blood)
  • Peptides (blood)
  • Periodontal Index
  • Placebos
  • Postmenopause (blood)
  • Procollagen (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: